Aug 20, 2020DaVita Clinical Research investigating presence of COVID-19 antibodies and genetic contributions to infection severity in patients
DaVita Clinical Research (DCR), a subsidiary of DaVita Inc., has begun enrollment on two clinical research trials to study how COVID-19 affects people with end stage kidney disease (ESKD) who are...
Aug 17, 2020
DaVita Inc. (NYSE: DVA) ("DaVita"), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care...
Aug 13, 2020The "Bridge to Your Dreams" program offers DaVita clinical teammates the opportunity to receive financial support to help them earn nursing degrees
DaVita has expanded a tuition and support program for its clinical teammates to help them earn an associate's degree in nursing. The program, named Bridge to Your Dreams, includes comprehensive...
Aug 11, 2020
DaVita Inc. (NYSE: DVA) announced today that its Board of Directors appointed a new independent director, Ms. Paula A. Price, to join the Board, effective September 1, 2020. "We are very excited...
Aug 6, 2020
DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the "2031 notes")....